Dan Dai
Impact in
-
- COVID-19 Clinical Research Studies
-
- Pharmacological Effects of Natural Compounds
Papers in
-
- Liver Disease Diagnosis and Treatment 2
- Hepatitis B Virus Studies 1
-
- Liver physiology and pathology 2
- Liver Diseases and Immunity 1
- Co-authors
- Kang Zhao (4 shared papers)Liming Liu (4 shared papers)Shuke Nie (1 shared paper)Jianjun Zhang (3 shared papers)Peng Du (1 shared paper)Xiang Cui (1 shared paper)Ying Zhou (2 shared papers)
- Journals
- Biomedicine & Pharmacotherapy (1 paper)Evidence-based Complementary and Alternative Medicine (1 paper)Chinese Medicine (1 paper)Open Forum Infectious Diseases (1 paper)
- Partner nations
- China
In The Last Decade
Dan Dai
4 papers receiving 164 citations
Peers
Comparison fields: 5 of 55
- Infectious Diseases 58
- Pharmacology 27
- Hematology 33
- Nutrition and Dietetics 43
- Complementary and alternative medicine 18
Countries citing papers authored by Dan Dai
This map shows the geographic impact of Dan Dai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dan Dai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dan Dai more than expected).
Fields of papers citing papers by Dan Dai
This network shows the impact of papers produced by Dan Dai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dan Dai. The network helps show where Dan Dai may publish in the future.
Co-authors
The 7 scholars most cited alongside Dan Dai, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 110 | |
| 2 | 2020 | 46 | |
| 3 | 2018 | 9 | |
| 4 | 2021 | 2 |
About Dan Dai
Dan Dai is a scholar working on Epidemiology, Hepatology, Infectious Diseases, Molecular Biology and Genetics, having authored 4 papers that have together received 167 indexed citations. Recurring topics across this work include Liver Disease Diagnosis and Treatment (2 papers), Liver physiology and pathology (2 papers), Phytochemistry and Biological Activities (1 paper), Hepatitis B Virus Studies (1 paper), Medicinal Plants and Bioactive Compounds (1 paper), Hemoglobinopathies and Related Disorders (1 paper), COVID-19 Clinical Research Studies (1 paper) and Liver Diseases and Immunity (1 paper). The work is most often cited by research in Infectious Diseases (58 citations), Pharmacology (27 citations), Hematology (33 citations), Nutrition and Dietetics (43 citations) and Complementary and alternative medicine (18 citations). Dan Dai has collaborated with scholars based in China. Frequent co-authors include Kang Zhao, Liming Liu, Shuke Nie, Jianjun Zhang, Peng Du, Xiang Cui and Ying Zhou. Their work appears in journals such as Biomedicine & Pharmacotherapy, Evidence-based Complementary and Alternative Medicine, Chinese Medicine and Open Forum Infectious Diseases.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.